The major factor attributing to the growth of the market increasing prevalence and incidence of chronic diseases like cancer, kidney diseases, and infectious diseases. According to World Health Organization(WHO), approximately 50,000 people are dying every day from infectious diseases and 30 new diseases have surfaced in the last 20 years and now together threaten the health of hundreds of millions of people.
Furthermore, the growing awareness about the advantages of using vial adaptors and the rising number of geriatric population are the major factors boosting the market growth. However, the availability of substitutes is a major drawback of market growth.
Key Market Trends
Infectious diseases segment holds a major share in the Vial Adaptors for Reconstitution Drug Market
Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi; the diseases can be spread, directly or indirectly, from one person to another.
According to the Centers for Disease Control and Prevention, 15.5 million people are getting diagnosed with infectious diseases only in the United States. As the incidence and prevalence of infectious diseases increase the demand of the adapters increases. As per the statistics, the increase in the number of patients is directly proportional to the market growth. Thus, considering the rising prevalence of infectious diseases the market is expected to grow over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall vial adaptors for reconstitution drug market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, established healthcare infrastructure, and availability of branded drugs are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and increase in number of research partnerships are some of the drivers expected to increase the market growth. The United States has a unique healthcare system among the developed countries. However, the cost of hospitals is very high in the country; the government or private insurance cover it. The rising prevalence of chronic diseases in the country is the prime factor responsible for the growth of the market in the country.
The vial adaptors for reconstitution drug market is moderately competitive and consists of several major players. Some of the market players are Miltenyi Biotec, Baxter, Randox Laboratories Ltd., West Pharmaceutical Services, Inc., B. Braun Medical Inc., Shimadzu Corporation, and Thermo Fisher Scientific
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Study Assumptions
1.3 Scope of the Study
4.2 Market Drivers
4.2.1 Increasing Prevalence of Infectious Diseases
4.2.2 Rising Geriatric Population
4.2.3 Increasing Awareness of the Advantages of the Vial Adaptors
4.3 Market Restraints
4.3.1 Availability of Substitutes
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.2 By Therapeutic Area
5.2.1 Autoimmune Diseases
5.2.2 Infectious Diseases
5.2.3 Metabolic Conditions
5.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle-East and Africa
5.3.5 South America
220.127.116.11 Rest of South America
6.1.1 Miltenyi Biotec
6.1.2 Baxter International Inc.
6.1.3 Randox Laboratories Ltd
6.1.4 Sartorious AG
6.1.5 West Pharmaceutical Services, Inc.
6.1.6 Thermo Fisher Scientific
6.1.7 Agilent Technologies
6.1.8 Becton, Dickinson and Company
6.1.9 B. Braun Medical Inc.
A selection of companies mentioned in this report includes:
- Miltenyi Biotec
- Baxter International Inc.
- Randox Laboratories Ltd
- Sartorious AG
- West Pharmaceutical Services, Inc.
- Thermo Fisher Scientific
- Agilent Technologies
- Becton, Dickinson and Company
- B. Braun Medical Inc.